Game-Changing HIV Shot Can’t Get to High-Risk Groups Fast Enough | Lenacapavir proved it's possible to prevent 100% of infections in women. Access and affordability are the next big hurdles.

You're viewing a single thread.

12 comments

"lenacapavir, a twice-yearly shot developed by Gilead Sciences for the prevention of HIV."

So its not a vaccine, but it would still be incredibly helpful in reducing the spread of of HIV.

12 comments